|
Publication |
|
Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects. Glück V, Tydykov L, Mader AL, Warda AS, Bertok M, Weidlich T, Gottwald C, Köstler J, Salzberger B, Wagner R, Koller M, Gessner A, Schmidt B, Glück T, Peterhoff D. Infection. 2022 Dec;50(6):1475-1481. doi: 10.1007/s15010-022-01817-8. Epub 2022 Apr 11. |
|
Association between Adverse Reactions and Humoral Immune Response No Longer Detectable after BNT162b2 Booster Vaccination. Bauernfeind S, Einhauser S, Tydykov L, Mader AL, Salzberger B, Hitzenbichler F, Mohr A, Burkhardt R, Wagner R, Peterhoff D. Vaccines (Basel). 2022 Sep 25;10(10):1608. doi: 10.3390/vaccines10101608.
|
|
Omicron's binding to sotrovimab, casirivimab, imdevimab, CR3022, and sera from previously infected or vaccinated individuals. Mader AL, Tydykov L, Glück V, Bertok M, Weidlich T, Gottwald C, Stefl A, Vogel M, Plentz A, Köstler J, Salzberger B, Wenzel JJ, Niller HH, Jantsch J, Wagner R, Schmidt B, Glück T, Gessner A, Peterhoff D. iScience. 2022 Apr 15;25(4):104076. doi: 10.1016/j.isci.2022.104076. Epub 2022 Mar 14. |
|
| | Last update Publications 17.12.2025 |
|